74 assets in Estrogen-Receptor Positive Breast Cancer

Therapeutic assets addressing Estrogen-Receptor Positive Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Toripalimab Estrogen-Receptor Positive Breast Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CCC (53)
Trastuzumab Emtansine Estrogen-Receptor Positive Breast Cancer	Dana-Farber Cancer Institute	P2	CCC (53)
N-Desmethyl-4-Hydroxytamoxifen Estrogen-Receptor Positive Breast Cancer	Atossa Therapeutics, Inc.	P2	CCC (51)
azd8421 Estrogen-Receptor Positive Breast Cancer	AstraZeneca	P1/2	CCC (48)
Inavolisib Estrogen-Receptor Positive Breast Cancer	Hoffmann-La Roche	P1/2	CCC (48)
Samuraciclib Estrogen-Receptor Positive Breast Cancer	Hoffmann-La Roche	P1/2	CCC (48)
Etx-19477 Estrogen-Receptor Positive Breast Cancer	858 Therapeutics, Inc.	P1/2	CC (47)
fwd1802 Estrogen-Receptor Positive Breast Cancer	Forward Pharmaceuticals Co., Ltd.	P1/2	CC (47)
Jab-2485 Estrogen-Receptor Positive Breast Cancer	Jacobio Pharmaceuticals Co., Ltd.	P1/2	CC (47)
Oxodotreotide Estrogen-Receptor Positive Breast Cancer	RayzeBio, Inc.	P1/2	CC (47)
Onapristone Estrogen-Receptor Positive Breast Cancer	University of Wisconsin, Madison	P2	CC (46)
Atirmociclib Estrogen-Receptor Positive Breast Cancer	Olema Pharmaceuticals, Inc.	P1	CC (43)
Atv-1601 Estrogen-Receptor Positive Breast Cancer	Atavistik Bio, Inc	P1	CC (43)
Bbi-355 Estrogen-Receptor Positive Breast Cancer	Boundless Bio, Inc.	P1	CC (43)
Bbi-825 Estrogen-Receptor Positive Breast Cancer	Boundless Bio, Inc.	P1	CC (43)
CD47/SIRPA-BLOCKING AGENT ALX148 Estrogen-Receptor Positive Breast Cancer	QuantumLeap Healthcare Collaborative	P1	CC (43)
Fam-Trastuzumab Deruxtecan-Nxki Estrogen-Receptor Positive Breast Cancer	QuantumLeap Healthcare Collaborative	P1	CC (43)
Futibatinib Estrogen-Receptor Positive Breast Cancer	Boundless Bio, Inc.	P1	CC (43)
Naptumomab Estafenatox Estrogen-Receptor Positive Breast Cancer	NeoTX Therapeutics Ltd.	P1	CC (43)
Obinutuzumab Estrogen-Receptor Positive Breast Cancer	NeoTX Therapeutics Ltd.	P1	CC (43)
Zanidatamab Estrogen-Receptor Positive Breast Cancer	QuantumLeap Healthcare Collaborative	P1	CC (43)
Avelumab Estrogen-Receptor Positive Breast Cancer	Royal Marsden NHS Foundation Trust	P1	CC (42)
op-3136 Estrogen-Receptor Positive Breast Cancer	Olema Pharmaceuticals, Inc.	P1	NR ()

Showing 51 to 74 of 74 assets

PreviousPage 2 of 2Next